Endothelin-1 antisense oligonucleotide suppresses the proliferation of glomerular mesangial cells stimulated with angiotensin-II

Kaohsiung Journal of Medical Sciences

Volumn 23, Issue 4, 2007, Pages 170-175

  Lee, Jia Jung ^a   Shin, Shyi Jang ^a,b   Chiu, Yi Wen ^a,b   Chen, Hung Chun ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiotensin II; Antisense oligonucleotide; Endothelin 1; Mesangial cell

Indexed keywords

ANGIOTENSIN II; ANTISENSE OLIGONUCLEOTIDE; ENDOTHELIN 1; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; GLOMERULOSCLEROSIS; MALE; MESANGIUM; MESANGIUM CELL; NONHUMAN; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RAT;

EID: 34248547751     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70393-6     Document Type: Article

References (15)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Brenner BM, Troy J, Ballermann BJ. Endothelin-dependent vascular response: mediators and mechanisms. J Clin Invest 1989;84:1373-8.
3. Koide H, Nakamura T, Ebihara I, et al. Endothelins in diabetic kidneys. Kidney Int 1995;48:S45-9.
4. Marsen TA, Schramek H, Dunn MJ. Renal actions of endothelin: linking cellular signaling pathways to kidney disease. Kidney Int 1994;45:336-44.
5. Beltinger C, Saragovi HU, Smith RM, et al. Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 1995;95:1814-23.
6. Popescu FD. Antisense- and RNA interference-based therapeutic strategies in allergy. J Cell Mol Med 2005;9:840-53.
7. Chen HC, Guh JY, Tsai JH, et al. Induction of heat shock protein 70 protects mesangial cells against oxidative injury. Kidney Int 1999;56:1270-3.
8. Chen HC, Chuang HS, Hsieh MC, et al. Effects of angiotensin II on the proliferation and fibronectin production of glomerular mesangial cells. Acta Nephrologica 2004;18:57-61.
9. Chen HC, Guh JY, Chang JM, et al. Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells. Nephron 2001;88:211-7.
10. Chen HC, Guh JY, Shin SJ, et al. Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med 2000;135:309-15.
11. Miyake H, Hara I, Fujisaw M, Gleave ME. Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects. Expert Rev Anticancer Ther 2005;5:1001-9.
12. Stein CA, Benimetskaya L, Mani S. Antisense strategies for oncogene inactivation. Semin Oncol 2005;32: 563-72.
13. Raizada MK, Der Sarkissian S. Potential of gene therapy strategy for the treatment of hypertension. Hypertension 2006;47:6-9.
14. Miyake H, Hara I, Gleave ME. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic. Int J Urol 2005;12:785-94.
15. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal disease. Pharmacol Rev 2001;52:11-34.